In a report released yesterday, Daniel Brennan from TD Cowen maintained a Hold rating on Qiagen (QGEN – Research Report), with a price target ...

Fintel reports that on February 5, 2025, TD Cowen initiated coverage of Palvella Therapeutics (NasdaqCM:PVLA) with a Buy ...

In a report released today, William Katz from TD Cowen maintained a Hold rating on Artisan Partners (APAM – Research Report), with a price ...

Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech company completed its $600 million acquisition of Ambry Genetics ...

OSI Systems, Inc. (NASDAQ: OSIS), today announced that it will present at the TD Cowen 46th Annual Aerospace & Defense Conference on Wednesday, February 12, 2025, at 10:45 AM ET.

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Noting that Ambry is a profitable testing laboratory that generates more than $300 million of revenue annually, the investment bank thinks that the deal will enable TEM to start generating positive ...

Wednesday, analysts at TD Cowen increased their price target on Fiserv (NYSE:FI) shares from $235.00 to $277.00, while retaining a Buy rating on the stock. The stock, currently trading at $229.53, has ...

Arthur J. Gallagher & Co. (AJG) stock saw a modest uptick, ending the day at $312.21 which represents a slight increase of $3.21 or 1.04% from the prior close of $309. The stock opened at $309 and ...

Knight-Swift Transportation Holdings Inc (KNX) stock saw a modest uptick, ending the day at $56.44 which represents a slight increase of $0.71 or 1.27% from the prior close of $55.73. The stock opened ...

In a report released Wednesday, the analysts incorporated several negative provisional pricing adjustments into their ...

Linde (NASDAQ:LIN – Get Free Report) will likely be posting its quarterly earnings results before the market opens on ...